A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility

被引:244
作者
Garcia-Effron, Guillermo [1 ]
Katiyar, Santosh K. [2 ]
Park, Steven [1 ]
Edlind, Thomas D. [2 ]
Perlin, David S. [1 ]
机构
[1] UMDNJ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ 07103 USA
[2] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/AAC.00262-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida parapsilosis has emerged as a common cause of invasive fungal infection, especially in Latin America and in the neonatal setting. C parapsilosis is part of a closely related group of organisms that includes the species Candida orthopsilosis and Candida metapsilosis. All three species show elevated MICs for the new echinocandin class drugs caspofungin, micafungin, and anidulafungin relative to other Candida species. Despite potential impacts on therapy, the mechanism behind this reduced echinocandin susceptibility has not been determined. In this report, we investigated the role of a naturally occurring Pro-to-Ala substitution at amino acid position 660 (P660A), immediately distal to the highly conserved hot spot 1 region of Fks1p, in the reduced-echinocandin-susceptibility phenotype. Kinetic inhibition studies demonstrated that glucan synthase from the C. parapsilosis group was 1 to 2 logs less sensitive to echinocandin drugs than the reference enzyme from C. albicans. Furthermore, clinical isolates of C. albicans and C. glabrata which harbor mutations at this equivalent position also showed comparable 2-log decreases in target enzyme sensitivity, which correlated with increased MICs. These mutations also resulted in 2.4- to 18.8-fold-reduced V-max. values relative to those for the wild-type enzyme, consistent with kinetic parameters obtained for C. parapsilosis group enzymes. Finally, the importance of the P660A substitution for intrinsic resistance was confirmed by engineering an equivalent P647A mutation into Fks1p of Saccharomyces cerevisiae. The mutant glucan synthase displayed characteristic 2-log decreases in sensitivity to the echinocandin drugs. Overall, these data firmly indicate that a naturally occurring P660A substitution in Fks1p from the C. parapsilosis group accounts for the reduced susceptibility phenotype.
引用
收藏
页码:2305 / 2312
页数:8
相关论文
共 36 条
[1]   Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections:: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003 [J].
Almirante, Benito ;
Rodríguez, Dolors ;
Cuenca-Estrella, Manuel ;
Almela, Manel ;
Sanchez, Ferran ;
Ayats, Josefina ;
Alonso-Tarres, Carles ;
Rodriguez-Tudela, Juan L. ;
Pahissa, Albert .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (05) :1681-1685
[2]  
[Anonymous], 2002, M27A2 CLSI
[3]   Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1 [J].
Balashov, Sergey V. ;
Park, Steven ;
Perlin, David S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :2058-2063
[4]   Echinocandins for candidemia in adults without neutropenia [J].
Bennett, John E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1154-1159
[5]   Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals [J].
Brito, Ligia R. ;
Guimaraes, Thais ;
Nucci, Marcio ;
Rosas, Robert C. ;
Almeida, Leila Paula ;
Da Matta, Daniel A. ;
Colombo, Arnaldo L. .
MEDICAL MYCOLOGY, 2006, 44 (03) :261-266
[6]   Prospective observational study of candidemia in Sao Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality [J].
Colombo, Arnaldo L. ;
Guimaraes, Thais ;
Silva, Ligia R. B. F. ;
Monfardini, Leila Paula de Almeida ;
Cunha, Anna Karenine B. ;
Rady, Patricia ;
Alves, Thelma ;
Rosas, Robert C. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (05) :570-576
[7]   Epidemiology of candidemia in Brazil:: a nationwide sentinel surveillance of candidemia in eleven medical Centers [J].
Colombo, Arnaldo L. ;
Nucci, Marcio ;
Park, Benjamin J. ;
Nouer, Simone A. ;
Arthington-Skaggs, Beth ;
da Matta, Daniel A. ;
Warnock, David ;
Morgan, Juliette .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2816-2823
[8]   Echinocandin antifungal drugs [J].
Denning, DW .
LANCET, 2003, 362 (9390) :1142-1151
[9]   Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors [J].
Douglas, CM ;
DIppolito, JA ;
Shei, GJ ;
Meinz, M ;
Onishi, J ;
Marrinan, JA ;
Li, W ;
Abruzzo, GK ;
Flattery, A ;
Bartizal, K ;
Mitchell, A ;
Kurtz, MB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2471-2479
[10]   THE SACCHAROMYCES-CEREVISIAE FKS1 (ETG1) GENE ENCODES AN INTEGRAL MEMBRANE-PROTEIN WHICH IS A SUBUNIT OF 1,3-BETA-D-GLUCAN SYNTHASE [J].
DOUGLAS, CM ;
FOOR, F ;
MARRINAN, JA ;
MORIN, N ;
NIELSEN, JB ;
DAHL, AM ;
MAZUR, P ;
BAGINSKY, W ;
LI, WL ;
ELSHERBEINI, M ;
CLEMAS, JA ;
MANDALA, SM ;
FROMMER, BR ;
KURTZ, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12907-12911